118 related articles for article (PubMed ID: 16546719)
1. Synergism between a siRNA targeted to survivin and 5-FU in inhibiting MCF-7 cell proliferation in vitro.
Zhang SQ; Zhang SH; Xue XH; Wang XJ; Jiang JT
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):251-4. PubMed ID: 16546719
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of survivin expression by small interfering RNA induces apoptosis in human breast carcinoma cell line MCF-7.
Li JX; Zhou KY; Liang T; Zhang YF
Ai Zheng; 2005 Mar; 24(3):268-72. PubMed ID: 15757525
[TBL] [Abstract][Full Text] [Related]
3. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350
[TBL] [Abstract][Full Text] [Related]
4. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
Hou JQ; He J; Wang XL; Wen DG; Chen ZX
Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
[TBL] [Abstract][Full Text] [Related]
5. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
Yuan-Jing F; Nan-Shan H; Lian X
Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
[TBL] [Abstract][Full Text] [Related]
6. Construction of survivin siRNA expression vector and its regulation on cell cycle and proliferation in MCF-7 cells.
Li LP; Liang NC; Luo CQ
Ai Zheng; 2004 Jul; 23(7):742-8. PubMed ID: 15248905
[TBL] [Abstract][Full Text] [Related]
7. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
8. Survivin associates with cell proliferation in renal cancer cells: regulation of survivin expression by insulin-like growth factor-1, interferon-gamma and a novel NF-kappaB inhibitor.
Sato A; Oya M; Ito K; Mizuno R; Horiguchi Y; Umezawa K; Hayakawa M; Murai M
Int J Oncol; 2006 Apr; 28(4):841-6. PubMed ID: 16525632
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
10. Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells.
Tsuji N; Asanuma K; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2005; 25(6B):3967-72. PubMed ID: 16309185
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effects of small interfering RNA targeting c-myc in combination with 5-fluorouracil on the growth in vitro and in vivo].
Sang JZ; Wang HT; Lou WH; Tian F; Jin HJ; Yuan LL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul; 46(7):566-71. PubMed ID: 22088286
[TBL] [Abstract][Full Text] [Related]
12. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake.
Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
Int J Oncol; 2007 Mar; 30(3):695-700. PubMed ID: 17273771
[TBL] [Abstract][Full Text] [Related]
14. Topotecan and small interfering RNA suppress survivin expression synergistically in Caki-1 renal cancer cells: Direct suppression of survivin and enhancement of transfection efficiency by topotecan.
Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
Int J Oncol; 2008 Jan; 32(1):171-6. PubMed ID: 18097556
[TBL] [Abstract][Full Text] [Related]
15. [Synergism of an antisense oligodeoxynucleotides targeted to hTERT in combination with chemotherapeutic drugs on inhibiting the proliferation of HepG2 cells].
Yang Y; Du QY; Wang SQ
Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):719-21. PubMed ID: 14697130
[TBL] [Abstract][Full Text] [Related]
16. [Growth of breast cancer cells is inhibited in vitro by cyclin E-siRNA].
He WS; Huang T; Ren JH
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):170-3. PubMed ID: 19615252
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nuclear factor-κB activity by small interfering RNA in esophageal squamous cell carcinoma cell lines.
Hatata T; Higaki K; Nanba E; Tatebe S; Ikeguchi M
Oncol Rep; 2011 Sep; 26(3):659-64. PubMed ID: 21617867
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells.
Chen T; Deng C
Int Immunopharmacol; 2008 Jul; 8(7):1006-11. PubMed ID: 18486912
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of survivin gene by vector-based short hairpin RNA technique induces apoptosis and growth inhibition in Burkitt's lymphoma Raji cell line.
Gu CM; Zhu YK; Ma YH; Zhang M; Liao B; Wu HY; Lin HL
Neoplasma; 2006; 53(3):206-12. PubMed ID: 16652189
[TBL] [Abstract][Full Text] [Related]
20. [Effect of siRNA transfection targeting VEGF gene on proliferation and apoptosis of human breast cancer cells].
Zhang X; Xu WH; Ge YL; Hou L; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):14-7. PubMed ID: 17210097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
